1 hr ago
Medical News Today
Rare gene could increase risk of schizophrenia, alcoholism and bipolar
A new study carried out by scientists from University College London in the UK has reported on the discovery of a rare gene variant found in about 1 in every 200 people that could increase the risk of developing alcohol dependence, bipolar disorder and schizophrenia.
Trending on the Topix Network
5 hrs ago
Asia News Network
SINGAPORE: Singapore researchers help identify new genes associated with schizophrenia
Singaporean researchers have contributed to a global study which has identified 83 genes associated with the risk of developing schizophrenia, which could mean earlier detection or new cures for the illness in the long run.
6 hrs ago
Findings point to biological mechanisms and pathways that may underlie schizophrenia
As part of a multinational, collaborative effort, researchers from the University of North Carolina School of Medicine and scores of other institutions from all over the world have helped identify over 100 locations in the human genome associated with the risk of developing schizophrenia , in what is the largest genomic study published on any ... (more)
Mon Jul 21, 2014
'Large gene find in schizophrenia'
Scientists have uncovered 80 previously unknown genes which may put people at risk of developing schizophrenia, research in Nature suggests.
Schizophrenia Gene Study May Point to New Treatment
Looking for a new schizophrenia drug is probably like looking for a needle in a haystack, but as of today, the haystack got a lot smaller.
Sun Jul 20, 2014
Antipsychotic Drugs Linked to Decrease in Brain Volume
A new study has confirmed a link between antipsychotic drugs and a slight, but measurable, decrease in brain volume in patients with schizophrenia .
Fri Jul 18, 2014
University of Cambridge
Antipsychotic drugs linked to slight decrease in brain volume
A study published today has confirmed a link between antipsychotic medication and a slight, but measureable, decrease in brain volume in patients with schizophrenia.
GNIF Brain Blogger
Self-Help for Schizophrenics
In spite of the existence of stigma, the first crucial step in dealing with schizophrenia is acceptance by that individual that he or she has a mental illness.
Mon Jul 14, 2014
The Globe and Mail
Eli Lilly NAFTA challenge 'without merit,' Ottawa says
The Indianapolis-based pharmaceutical company has been waging a battle on what it claims is a spate of Canadian court rulings that violate international rules and have unfairly cost the company two of its key patents, allowing cheaper generic versions to hit the market in Canada.
Gainers and losers: The biggest moves in life science stocks last week
The FDA's approval of the Sensus device for over-the-counter sales caused NeuroMetrix stock to jump 14 percent last week.
Janssen Pharmaceuticals Seeks Expanded Label for Once-Monthly...
Janssen Pharmaceuticals, Inc. today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration seeking a label change that, if approved, would include new data showing significantly delayed time to relapse in patients prescribed once-monthly atypical long-acting antipsychotic INVEGA SUSTENNA compared ... (more)
Fri Jul 11, 2014
Addressing the unmet needs of patients with persistent negative...
The negative symptoms of schizophrenia represent an impairment of normal emotional responses, thought processes and behaviors, and include blunting or flattening of affect, alogia/aprosody, avolition/apathy, anhedonia, and asociality.
Wed Jul 09, 2014
Customer Interaction Solutions
Alkermes Announces Notices of Allowance for U.S. Patents for Four CNS Pipeline Candidates
Alkermes plc today announced that the United States Patent and Trademark Office has issued Notices of Allowance for four of Alkermes' pipeline candidates for the treatment of central nervous system disorders: aripiprazole lauroxil, ALKS 5461, ALKS 3831 and ALKS 7106.
Tue Jul 08, 2014
Newron Pharmaceuticals Establishes U.S. Operations
July 8, 2014 - Newron Pharmaceuticals S.p.A. , a research and development company focused on novel CNS and pain therapies, today announces the start of its operations in the United States.
To understand the brain you need electronic engineers too
There is a rapidly growing intersection between electronic engineering and neuroscience .
Mon Jul 07, 2014
Randomized, double-blind trial of olanzapine versus placebo in...
This study assessed the efficacy of olanzapine in delaying or preventing conversion to psychosis and reducing symptoms in people with prodromal symptoms of schizophrenia.
Sleep Deprived? That's What Psychosis Is Like
In psychosis, there is a loss of contact with reality and this is associated with hallucinations and delusions.
Thu Jul 03, 2014
You Are Not Alone in Your Diagnosis of Mental Illness
In the eight years I've lived with schizophrenia I've seen horrible days and I've seen days where the sun seemed to shine just right on my face and strike a certain happiness in my soul.
Tue Jul 01, 2014
Highlights of this issue [Highlights of this issue]
Dementia commonly presents comorbid behavioural and psychological disturbance, which cause significant distress to the patient and carers alike, and are challenging to manage effectively.
Mon Jun 30, 2014
A Tangled Web: Wheat, Schizophrenia, and Infection
Researchers have been chasing the elusive links between gluten, infections, and major mental illness for decades.